MARKSANS PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Marksans Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.26₹ -0.45
As on Jan 14, 2026, 4:01 PM IST
Marksans Pharma Price Performance
Today's LowToday's High
₹172.00₹173.55
₹172.90
52 Weeks' Low52 Weeks' High
₹162.05₹276.15
₹172.90
Open Price
₹172.95
Prev. Close
₹173.35
Volume
9,591
Over the last 5 years, the share price of Marksans Pharma has gained 23.57% CAGR. Over the past year, the corresponding return has been -32.96%.
Marksans Pharma’s current P/E of 22.28x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Marksans Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Marksans Pharma | -5.23 | -9.38 | -4.40 | -33.73 | -32.96 | 37.92 | 23.57 |
| Sun Pharmaceutical Industries | -4.60 | -5.38 | 2.81 | 1.10 | -3.86 | 17.98 | 22.88 |
| Divi's Laboratories | -4.39 | 0.06 | -3.18 | -6.38 | 5.88 | 23.97 | 11.26 |
| Torrent Pharmaceuticals | -2.15 | 5.88 | 13.75 | 17.50 | 23.01 | 36.63 | 23.48 |
| Cipla | -2.23 | -4.82 | -7.63 | -3.37 | -0.93 | 10.61 | 11.29 |
| Lupin | -0.84 | 5.02 | 13.28 | 14.04 | 1.84 | 42.61 | 14.70 |
| Dr. Reddy's Laboratories | -4.08 | -6.91 | -3.66 | -4.72 | -10.87 | 11.27 | 2.34 |
| Mankind Pharma | -3.01 | 4.62 | -7.96 | -16.96 | -16.08 | 16.33 | 9.50 |
| Zydus Lifesciences | -4.61 | -3.99 | -9.67 | -8.67 | -11.62 | 26.30 | 11.94 |
| Alkem Laboratories | 0.49 | 3.60 | 5.89 | 20.20 | 10.36 | 24.18 | 13.32 |
| Aurobindo Pharma | -4.19 | -0.17 | 5.35 | 3.93 | 0.73 | 38.42 | 4.29 |
| Abbott India | -2.05 | 0.05 | -7.29 | -18.84 | -1.22 | 8.19 | 13.21 |
| Laurus Labs | -3.34 | 8.63 | 24.47 | 32.37 | 91.99 | 45.49 | 24.34 |
| Biocon | -2.12 | -2.96 | 7.75 | -0.05 | -2.24 | 14.80 | -4.08 |
| Glenmark Pharmaceuticals | -4.88 | 1.24 | 6.14 | -9.39 | 32.68 | 68.53 | 31.03 |
| GlaxoSmithKline Pharmaceuticals | -2.89 | -7.31 | -13.62 | -25.11 | 14.90 | 22.37 | 9.48 |
| Ipca Laboratories | 0.20 | 5.23 | 16.29 | 4.09 | -4.50 | 20.47 | 7.15 |
| Anthem Biosciences | -5.04 | -10.91 | -19.39 | -14.75 | -14.75 | -5.18 | -3.14 |
| Ajanta Pharma | -5.19 | 2.50 | 13.06 | 2.12 | -3.90 | 32.03 | 18.10 |
| Emcure Pharmaceuticals | 3.04 | 12.71 | 17.50 | 16.15 | 16.47 | 5.02 | 2.98 |
Over the last one year, Marksans Pharma has declined 32.96% compared to peers like Sun Pharmaceutical Industries (-3.86%), Divi's Laboratories (5.88%), Torrent Pharmaceuticals (23.01%). From a 5 year perspective, Marksans Pharma has outperformed peers relative to Sun Pharmaceutical Industries (22.88%) and Divi's Laboratories (11.26%).
Marksans Pharma Financials
Marksans Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 177.42 | 175.39 |
| 10 | 179.07 | 177.51 |
| 20 | 181.28 | 180.19 |
| 50 | 186.38 | 183.4 |
| 100 | 180.33 | 189.37 |
| 200 | 207.72 | 201.61 |
Marksans Pharma Share Holding Pattern
In the latest quarter, Marksans Pharma remained same as its previous close in promoter holding, while DII stake increased to 5.91%, FII holding fell to 8.13%, and public shareholding moved up to 42.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Marksans Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 33,35,509 | 0.34 | 62.69 | |
| 27,94,081 | 1.09 | 52.51 | |
| 21,59,816 | 0.6 | 40.59 | |
| 20,19,995 | 0.69 | 37.97 | |
| 7,55,000 | 1.26 | 14.19 | |
| 7,01,714 | 0.28 | 13.19 |
* Excluding Index & Arbitrage Funds
Marksans Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 13, 2026, 9:02 PM IST | Marksans Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 09, 2026, 9:02 PM IST | Marksans Pharma - Board Meeting Intimation for Declaration Of Quarterly Results For The Quarter Ended December 31, 2025 |
| Nov 21, 2025, 5:43 AM IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 20, 2025, 6:37 PM IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 19, 2025, 4:46 PM IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Marksans Pharma
Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1174.37 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address11th Floor, Grandeur, Veera Desai Extension Road, Mumbai Maharashtra 400053
- Contact
Management
- Mr. Mark SaldanhaChairman & Managing Director
- Mrs. Sandra SaldanhaWhole Time Director
- Mr. Varddhman V JainWhole Time Director
- Dr. Sunny SharmaNon Executive Director
- Mr. Srinivas MishraIndependent Director
- Mr. Digant Mahesh ParikhIndependent Director
- Mr. Abhinna Sundar MohantyIndependent Director
- Mrs. Shailaja VardhanIndependent Director
FAQs on Marksans Pharma Share Price
What is the share price of Marksans Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Marksans Pharma is ₹172.90 as on Jan 14, 2026.
What kind of stock is Marksans Pharma?
The Marksans Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Marksans Pharma?
The market cap of Marksans Pharma is ₹7,835.20 Cr as on Jan 14, 2026.
What are today's High and Low prices of Marksans Pharma?
Today’s highest and lowest price of Marksans Pharma are ₹173.55 and ₹172.00.
What are the 52 Week High and 52 Week Low of Marksans Pharma?
The 52-week high/low is the highest and lowest price at which Marksans Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Marksans Pharma is ₹276.15 and 52-week low of Marksans Pharma is ₹162.05 as on Jan 14, 2026.
How has the Marksans Pharma performed historically in terms of returns?
The Marksans Pharma has shown returns of -0.26% over the past day, -9.38% for the past month, -4.4% over 3 months, -32.96% over 1 year, 37.92% across 3 years, and 23.57% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Marksans Pharma?
P/E ratio of and PB ratio of Marksans Pharma are 22.28 and 2.91 on Jan 14, 2026. While the company gives a dividend yield of 0.46 per annum.
Marksans Pharma News
✕
Market Pulse